Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Diabetic Footwear– Insights
Diabetes is a chronic disease caused by lack or lower levels of insulin in the body. A person suffering from diabetes may develop sores, abscesses, ulcers, or loss of sensation in parts of the body, predominantly in feet. The exceptional design of diabetic footwear aids in protecting the patient’s feet from injuries. According to World Health Organization (WHO), in 1980, the number of diabetic patients was108 Mn, which in reached 422 Mn in 2014. Primary reason behind this growth in number is the busy lifestyle of urban society along with increased intake of sugar and other artificial sweeteners.
Unique properties of diabetic footwear help heal a variety of diabetic conditions such as inadequate blood circulation to legs and thus, help address foot pain and ulcers. Diabetes is classified as Type 1, Type 2, and gestational diabetes. Type 2 diabetes, the most common type, is caused mainly due to obesity and reduced physical activity. Global diabetic footwear market is largely driven by the rising cases of diabetes, increased spending on diabetes treatment, and growing geriatric population, characterized by high incidence of diabetes.
Men were the biggest end users of diabetic footwear globally in 2016. According to a report by National Health Service, males are more prone to diabetes and need to gain far less weight than females to develop the disease. However, women are expected to be the fastest growing end users of diabetic footwear during the forecast period. Diabetic footwear products include sandals, shoes, and slippers. Availability of diabetic footwear in different models gained them wide acceptance among the public for use in any occasion.
Asia Pacific is the most dominant region in the global diabetic footwear market. According to National Center for Biotechnology Information, around 150 Mn diabetic patients reside in this region, with over 95% diagnosed with Type 2 diabetes. The region accounted for 36.30% of the total market share in 2016, in terms of revenue. The dominance is on account of the large population suffering from diabetes coupled with an increase in expenditure on diabetes treatment and rise in the size of geriatric population. China and India are home to one-third of the total global population with India being dubbed as ‘The Diabetes Capital of the World’. Increase in disposable incomes has resulted in a rise in demand for diabetic footwear in the Asia Pacific region. Also, an increase in diabetic populace coupled with the availability of relatively cheap products from local players in India and China augments the growth of diabetic footwear market in the region.
North America is the second largest region, in terms of value, in the global diabetic footwear market, closely followed by Europe. North America was valued at US$ 1,179.9 Mn in 2016. Various government initiatives have been put forth in the region to raise awareness on causes of diabetes among public. For instance, American Diabetes Association is spread throughout the U.S. to raise alertness amongst the public on precautions and treatment pertaining to diabetes. In addition to this, National Institute of Diabetes has decided to follow November of every year as National Diabetes Month. The diabetic footwear market is expected to grow at a significant rate, owing to the introduction of new brands in the market. Growing popularity of e-commerce is expected to have a positive impact on the growth of the global diabetic footwear market. Large geriatric population in North America and Europe accounted for a rise in number of diabetic cases in these regions. According to Population Reference Bureau, Statistics Canada and EU, geriatric population reported in North America was 51 million and 94 million in Europe. The aforementioned factor is expected to propel the market growth in North America over the forecast period.
The global diabetic footwear market was valued at US$ 5,331.8 Mn in 2016 and is expected to expand at a CAGR of 7.86%, in terms of revenue, during 2017 – 2025.
Figure 1. Global Diabetic Footwear Market Share, By Region
Source: Coherent Market Insights 2017
Asia Pacific and North America accounted for major shares in the global diabetic footwear market, both in terms of revenue and volume, in 2016 and are expected to dominate over the forecast period. However, lack of awareness among people in rural areas of emerging economies and premium pricing is a major restraint for the market growth, especially in Asia Pacific.
Major Players in the Global Diabetic Footwear Market
Some of the major players in the global diabetic footwear market include Podartis S.r.l., Aetrex Worldwide Inc., Orthofeet Inc., Etonic Shoes, Drew Shoe, Dr. Comfort, DARCO International, Duna S.r.l, and Hong Kong Grace Shoes, among others.